The global mRNA vaccine market was valued at US$ 21.7 billion in 2023, reflecting the tail-end of heightened pandemic-era sales. However, with mass COVID-19 immunization campaigns tapering off and healthcare systems focusing on broader preventive strategies, the market is projected to contract at a compound annual growth rate (CAGR) of -4.3% over the forecast period. By 2034, the market size is expected to shrink to approximately US$ 9.6 billion. This negative growth trajectory marks a shift from explosive demand to market normalization. Still, it doesn't spell obsolescence-instead, it underlines a maturing sector poised to redefine its long-term utility across cancer immunotherapy, influenza, and personalized medicine.
Access key findings and insights from our Report in this sample - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=85998
Market Segmentation
The mRNA vaccine market can be segmented based on application, end user, and
distribution channel. By application, infectious diseases currently dominate
the market, largely due to the ongoing need for COVID-19 boosters and growing
interest in flu, RSV, and Zika virus vaccines. However, a significant rise in
research and development for oncology-related mRNA vaccines suggests a shift
toward therapeutic applications. By end user, hospitals and specialty clinics
remain primary distribution centers, while government procurement programs have
historically played a pivotal role in driving volume. In the coming years,
increased private sector engagement, especially in cancer care, is expected to
reshape distribution dynamics.
Regional Analysis
North America continues to lead the global mRNA vaccine market, owing to
advanced healthcare infrastructure, early adoption of new technologies, and
strong investment by companies such as Pfizer and Moderna. Europe follows
closely, driven by significant government investments and a robust biopharma
pipeline. Asia-Pacific, although currently in a nascent stage, is emerging as a
significant player, with countries like India and China ramping up mRNA vaccine
production capacity. Notably, companies such as Gennova Biopharmaceuticals Ltd
in India and Aimei Vaccine Co., Ltd in China are becoming influential regional
players. Africa and Latin America, while still underserved, present potential
opportunities for market expansion, especially with regard to infectious
disease management.
Explore our report to uncover in-depth insights - https://www.transparencymarketresearch.com/mrna-vaccine-market.html
Competitive Landscape
The competitive landscape of the mRNA vaccine market is led by Pfizer, Inc.,
Moderna Inc., Novartis AG, Sanofi, Arcturus Therapeutics, Gennova
Biopharmaceuticals Ltd, and Aimei Vaccine Co., Ltd. These players are profiled
extensively in terms of company overview, financial performance, strategic
initiatives, product portfolio, and recent developments. Pfizer and Moderna
continue to dominate due to their early-mover advantage and extensive
manufacturing networks. However, emerging firms in Asia and Europe are closing
the gap with localized innovation and government backing. The post-pandemic
period has seen companies diversify their mRNA pipelines to cover a broader
range of indications, including autoimmune disorders and rare diseases.
About Transparency Market Research
Transparency Market Research, a global market research company registered at
Wilmington, Delaware, United States, provides custom research and consulting
services. Our exclusive blend of quantitative forecasting and trends analysis
provides forward-looking insights for thousands of decision makers. Our
experienced team of Analysts, Researchers, and Consultants use proprietary data
sources and various tools & techniques to gather and analyses information.
Our data repository is continuously updated and revised by a team of research experts,
so that it always reflects the latest trends and information. With a broad
research and analysis capability, Transparency Market Research employs rigorous
primary and secondary research techniques in developing distinctive data sets
and research material for business reports.
Contact:
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453